THG FY 2025 presentation: H2 recovery drives return to profit

THG reported FY2025 revenue of £1.72bn (+2.3%) and swung to an operating profit of £8.1m from a £147.9m loss a year earlier, with adjusted EBITDA of £76.6m (4.5% of revenue). Free cash flow was negative £51.8m, but management guides to positive FCF of £25m–£50m in FY2026 and has extended debt facilities to 2029; the Ingenuity demerger is complete. Beauty revenue was £1.11bn (H2 recovery +5.4%), Nutrition £609.1m, and management highlighted margin improvements, AI-driven payroll savings and portfolio rationalisation as drivers of the turnaround.

Analysis

THG’s apparent operational reset amplifies winners beyond the stock itself: vertically integrated brand-owners with direct control of formulation, manufacturing and DTC channels stand to capture a disproportionate share of margin recovery across beauty and nutrition. Conversely, multi-brand marketplace operators and legacy bricks-and-mortar chains face margin pressure as exclusive launches and short-form-commerce distribution compress SKU-level wholesaling economics; expect upward price pressure on specialist 3PL capacity in the UK/US as brands reallocate fulfillment closer to home markets.

A key non-linear exposure is commodity-driven margin convexity in nutrition ingredients. If input prices mean-revert, incremental gross margin falls flow almost straight to the bottom line for in-house manufactured SKUs; if they spike again, inventory and promotional risk re-emerges quickly because the business model now leans more on margin-accretive categories and tighter SKU economics. Timing here is 1–4 quarters for commodity moves to show through and 2–6 quarters for retail channel shifts to normalize working capital.

Execution risk clusters around three operational levers: wholesale/retail channel mix, cadence of exclusive launches (SKU proliferation increases inventory risk), and distribution footprint rebalancing (short-term cost drag, long-term margin benefit). Monitoring weekly/monthly sell-through, AUR trends on social platforms, and 3PL rate moves will give earlier read-throughs than quarterly statements; a single material working-capital miss would likely reprice the story within days, whereas sustained margin improvement would take multiple quarters to be rewarded.

The market reaction has likely already baked in a benign execution path; that creates an asymmetric opportunity to express conviction with structure. If you believe the margin and cash conversion inflection is durable, favor equity or call exposure sized for a 6–12 month thesis; if you’re skeptical, use a pair or downside-protected option structure to capture a short-term unwind while limiting tail losses on unexpected execution success.

Key Decisions for Investors

• Long THG.L (30–50bps position): buy the equity on a pullback within the next 2–6 weeks, target a 40–60% upside over 6–12 months if margin leverage continues; place a stop-loss at 20% below entry to protect against a working-capital reversal.
• Pair trade — long THG.L / short ASC.L (ASOS) (gross 40bps each): express a rotation from fast-fashion to beauty/nutrition DTC; horizon 6–9 months. Expect asymmetric payoff if beauty exclusives and short-form commerce sustain higher AOVs; limit pair downside with a 25% stop on the short leg and 15% on the long leg.
• Long WIN.L (Wincanton) (25bps): tactical 3–9 month play to capture higher demand for regional fulfillment services as brands rebalance distribution to home territories. Target 25–35% upside; sell if contract wins or volume indicators do not materialize within 3 quarters.
• Options: buy a THG.L call spread (6–12 month expiry) instead of naked calls to cap premium cost — e.g., long nearer-term call and short a higher strike to create 2:1 upside potential vs premium paid. Use this if you want leveraged upside to a successful cash-conversion thesis while capping downside to the option premium.